| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $86,548,049 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01CA285607 | Mechanisms and Therapy of Radiation Resistance in Breast Cancer | 000 | 3 | NIH | 5/7/2026 | $526,484 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R00DK135923 | Defining a novel transcriptional regulator of intestinal health and inflammation | 001 | 3 | NIH | 3/13/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01CA276863 | Novel Therapeutic Approaches for Aggressive Prostate Cancer | 000 | 4 | NIH | 5/6/2026 | $383,156 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01DK133265 | Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM) | 000 | 4 | NIH | 4/6/2026 | $162,940 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01DK133265 | Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM) | 000 | 4 | NIH | 4/6/2026 | $688,104 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01AG083881 | Transcriptomics-based identification of cell type specific host genes and gene networks perturbed by HSV-1 in cerebral organoids. | 000 | 3 | NIH | 5/6/2026 | $849,117 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01AG053355 | Role of methylation-dependent pathways in aging and stress | 000 | 9 | NIH | 5/6/2026 | $613,602 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R37AI155901 | The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation | 000 | 6 | NIH | 4/6/2026 | $608,703 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F31AI197867 | Defining mechanisms that regulate plasma membrane rupture | 000 | 1 | NIH | 4/1/2026 | $37,577 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01DK136013 | Mechanical regulation of intestine stem cell-mediated tissue homeostasis in Drosophila | 000 | 4 | NIH | 5/6/2026 | $368,500 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F30AI197875 | Investigating the cellular and molecular mechanisms of periventricular inflammation in neuroinflammatory CNS | 002 | 1 | NIH | 4/10/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R03HG014806 | Developing a cCRE-Centric Infrastructure in AnVIL to Characterize Variant Effects on Gene Regulation | 000 | 1 | NIH | 4/2/2026 | $418,750 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R35GM152194 | Systems and Network-level Regulation of Cell Death | 000 | 3 | NIH | 4/13/2026 | $418,750 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F31AI197867 | Defining mechanisms that regulate plasma membrane rupture | 001 | 1 | NIH | 4/14/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01NS076991 | Oligodendrocyte-focused rAAV gene therapy strategies for Canavan disease and Leukodystrophies | 001 | 12 | NIH | 4/28/2026 | $53,042 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F30AI188981 | The role of caspase-3 mediated cleavage of VPS4A in restricting HSV-1 | 001 | 2 | NIH | 4/24/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R25HL092610 | UMass Chan Medical School Summer Undergraduate Research Program | 000 | 18 | NIH | 3/20/2026 | $165,302 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01NS101986 | Understanding Frontotemporal Dementia Using Drosophila and iPSC Models | 000 | 8 | NIH | 4/13/2026 | $625,941 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | P40OD028116 | Nonhuman Primate Antibody Resource for Immune Cell Depletion | 001 | 7 | NIH | 4/27/2026 | $216,560 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F30AI181515 | Characterization of Enterovirus 68 3C Protease For the Development of Robust and Potent Direct-Acting Antiviral Inhibitors | 001 | 3 | NIH | 4/2/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | H7600689 | Ryan White Part C Outpatient EIS Program | 00 | 25 | HRSA | 3/24/2026 | $80,152 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F31AI189160 | Temporal Regulation of mRNA Biogenesis in Immune Responses | 001 | 2 | NIH | 4/2/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F32AI176649 | Glutamine Starvation as a Means to Enhance Antibiotic Efficacy against M. tuberculosis | 000 | 3 | NIH | 4/24/2026 | $81,580 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R35GM150669 | Discovery and characterization of bacterial cell envelope assembly and remodeling networks that modulate tolerance to antibiotics | 000 | 4 | NIH | 4/14/2026 | $418,750 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01AG085308 | Role of Peripheral Insulin Resistance and Inflammation in Alzheimer’s Disease | 000 | 3 | NIH | 4/10/2026 | $737,005 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01GM155648 | Interrogating the roles of truncated/mutated inverted terminal repeat sequences in adeno-associated virus vectors in transgene stability through episome formation and host cell genome integration | 000 | 1 | NIH | 4/10/2026 | $1,675,000 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F30AI197875 | Investigating the cellular and molecular mechanisms of periventricular inflammation in neuroinflammatory CNS | 001 | 1 | NIH | 4/10/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F30DA058525 | Implementation of Medications for Opioid Use Disorder in Massachusetts Jails | 001 | 3 | NIH | 3/24/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01CA271613 | Role of EZH2 as a Driver and Therapeutic Target of Hepatocellular Carcinoma | 000 | 4 | NIH | 4/10/2026 | $461,997 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | P50MH129701 | The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES) | 001 | 4 | NIH | 3/25/2026 | $3,194,743 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01HD104971 | Characterization of the gene regulatory network governing the first cell fate decision in mammalian embryonic development | 000 | 5 | NIH | 3/24/2026 | $515,898 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01NS106985 | A Chemosensory-Mechanotransduction System Regulating Ventricular Size and Brain Function | 000 | 7 | NIH | 3/24/2026 | $555,440 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01NS104022 | Expanding the Chemical Diversity of Therapeutic Oligonucleotides | 000 | 9 | NIH | 3/23/2026 | $688,196 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R21AI193666 | Role of SLC46A3 in the pathogenesis of inflammatory bowel disease | 000 | 1 | NIH | 4/22/2026 | $251,250 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01HD072122 | Epigenetic control of developmental gene regulation | 000 | 15 | NIH | 4/16/2026 | $482,124 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R35GM133762 | Tracking transcriptome diversity in real-time | 001 | 7 | NIH | 3/19/2026 | $47,905 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01NR021257 | Examining the Effectiveness of School-based Health Centers (SBHCs) to Improve Pediatric Asthma Care | 000 | 1 | NIH | 4/17/2026 | $3,480,544 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R25GM121220 | Pathway to graduate study post-baccalaureate training program | 000 | 9 | NIH | 4/15/2026 | $407,161 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | K12TR005450 | 2/3 CTSA K12 Program at University of Massachusetts | 000 | 1 | NIH | 3/19/2026 | $949,994 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01AR081355 | Cellular and molecular regulators of melanocyte regeneration | 000 | 4 | NIH | 3/19/2026 | $388,205 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | UG4LM012347 | Network of the National Library of Medicine (NNLM) UG4 cooperative agreement Funded Extension 2026-2027 | 001 | 10 | NIH | 4/16/2026 | $1,035,742 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01CA269711 | Targeting the detoxification function of the enzyme KDSR for cancer therapy | 001 | 4 | NIH | 4/16/2026 | $38,261 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01CA258712 | Targeting MTOR signaling in pancreatic cancer | 000 | 5 | NIH | 4/17/2026 | $532,928 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R35HL171534 | Developmental origins of pericyte heterogeneity | 001 | 3 | NIH | 3/19/2026 | $35,175 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R35GM131741 | Genetic control of developmental timing | 001 | 7 | NIH | 3/11/2026 | $84,427 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | F31DK145217 | Determine the role of a monocarboxylate transporter in metabolism and intestinal motility | 001 | 1 | NIH | 3/31/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01DA062441 | Role of Striatal Molecular Rhythms in Sleep and Opioid Use Disorder | 000 | 2 | NIH | 4/17/2026 | $791,633 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | K99AG086405 | Apoptotic Dysregulation Across Cell Types in Aging and Neurodegeneration | 000 | 2 | NIH | 5/8/2026 | $132,472 |
| | 2026 | 2026 | UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | 55 LAKE AVE N | WORCESTER | MA | 01655-0002 | WORCESTER | USA | R01NR021826 | The Re-Engineered Discharge for Diabetes Care Transitions (REDDCAT2): Screening and Addressing SDOH Needs at Hospital Discharge | 000 | 3 | NIH | 5/8/2026 | $747,672 |
|
